Canada - engelsk - Health Canada

viiv healthcare ulc - fosamprenavir (fosamprenavir calcium) - suspension - 50mg - fosamprenavir (fosamprenavir calcium) 50mg - hiv protease inhibitors

Canada - engelsk - Health Canada

glaxosmithkline inc - amprenavir - capsule - 50mg - amprenavir 50mg - hiv protease inhibitors

Canada - engelsk - Health Canada

glaxosmithkline inc - amprenavir - capsule - 150mg - amprenavir 150mg - hiv protease inhibitors

Canada - engelsk - Health Canada

glaxosmithkline inc - amprenavir - liquid - 15mg - amprenavir 15mg - hiv protease inhibitors

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

viiv healthcare uk ltd - fosamprenavir calcium - tablet - 700mg

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

viiv healthcare uk ltd - fosamprenavir calcium - oral suspension - 50mg/1ml

USA - engelsk - NLM (National Library of Medicine)

state of florida doh central pharmacy - fosamprenavir calcium (unii: id1gu2627n) (amprenavir - unii:5s0w860xnr) - lexiva® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection. the following points should be considered when initiating therapy with lexiva plus ritonavir in protease inhibitor-experienced patients: lexiva is contraindicated: drug class/drug name clinical comment alpha 1-adrenoreceptor antagonist: alfuzosin potentially increased alfuzosin concentrations can result in hypotension. antiarrhythmics: flecainide, propafenone potential for serious and/or life-threatening reactions such as cardiac arrhythmias secondary to increases in plasma concentrations of antiarrhythmics if lexiva is co-prescribed with ritonavir . antimycobacterials: rifampina may lead to loss of virologic response and possible resistance to lexiva or to the class of protease inhibitors. ergot derivatives: dihydroergotamine, ergonovine, ergotamine, methylergonovine potential for serious and/or life-threatening reactions such as acute ergot toxicity characterized by pe

Namibia - engelsk - Namibia Medicines Regulatory Council

glaxosmithkline s.a (pty) ltd - amprenavir - soft capsules - amprenavir soft capsules, 50mg

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amprenavir 15 mg/ml - oral solution - 15 mg/ml - active: amprenavir 15 mg/ml excipient: acesulfame potassium citric acid grape bubblegum flavour 998 hydrochloric acid macrogol 400 mentha x piperita menthol propylene glycol purified water saccharin sodium sodium chloride sodium citrate dihydrate sodium hydroxide tocofersolan

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amprenavir 150mg - soft gelatin capsule - 150 mg - active: amprenavir 150mg excipient: gelatin macrogol 400 propylene glycol tocofersolan